On June 10, Moderna said its experimental combination vaccine for COVID-19 and influenza surpassed the efficacy of existing shots in a phase 3 trial.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Moderna's combo flu, COVID-19 shot succeeds in phase 3 trial
